Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Mayeno

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Trends in Biotechnology|September 1, 1994
Eosinophilia-myalgia syndrome and tryptophan production: a cautionary taleA N Mayeno, G J Gleich
Journal of Leukocyte Biology|February 1, 1992
Granule-associated flavin adenine dinucleotide (FAD) is responsible for eosinophil autofluorescenceA N Mayeno, K J Hamann, G J Gleich
Biochemistry and Molecular Biology International|November 1, 1995
1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitroJ G Zangrilli, A N Mayeno, V Vining, et al.
The Journal of Biological Chemistry|April 5, 1989
Eosinophils preferentially use bromide to generate halogenating agentsA N Mayeno, A J Curran, R L Roberts, et al.
Toxicology and Applied Pharmacology|May 1, 1994
Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndromeH Sidransky, E Verney, J W Cosgrove, et al.
Autoimmunity|January 1, 1996
EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analogW C Buss, J Stepanek, A D Bankhurst, et al.
Neurology|December 1, 1994
1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndromeA M Emslie-Smith, A N Mayeno, S Nakano, et al.
Mayo Clinic Proceedings|December 1, 1992
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?A N Mayeno, E A Belongia, F Lin, et al.
Toxicology Letters|July 21, 1997
On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndromeB L Williamson, L M Benson, A J Tomlinson, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2011
A physiologically based pharmacokinetic model for capreomycinB Reisfeld, C P Metzler, M A Lyons, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Trends in Biotechnology|September 1, 1994
Eosinophilia-myalgia syndrome and tryptophan production: a cautionary taleA N Mayeno, G J Gleich
Journal of Leukocyte Biology|February 1, 1992
Granule-associated flavin adenine dinucleotide (FAD) is responsible for eosinophil autofluorescenceA N Mayeno, K J Hamann, G J Gleich
Biochemistry and Molecular Biology International|November 1, 1995
1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitroJ G Zangrilli, A N Mayeno, V Vining, et al.
The Journal of Biological Chemistry|April 5, 1989
Eosinophils preferentially use bromide to generate halogenating agentsA N Mayeno, A J Curran, R L Roberts, et al.
Toxicology and Applied Pharmacology|May 1, 1994
Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndromeH Sidransky, E Verney, J W Cosgrove, et al.
Autoimmunity|January 1, 1996
EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analogW C Buss, J Stepanek, A D Bankhurst, et al.
Neurology|December 1, 1994
1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndromeA M Emslie-Smith, A N Mayeno, S Nakano, et al.
Mayo Clinic Proceedings|December 1, 1992
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?A N Mayeno, E A Belongia, F Lin, et al.
Toxicology Letters|July 21, 1997
On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndromeB L Williamson, L M Benson, A J Tomlinson, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2011
A physiologically based pharmacokinetic model for capreomycinB Reisfeld, C P Metzler, M A Lyons, et al.
Pageof 2